What they were paid
ANI PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $97,477 | $248,323 | $0 | $0 | $345,800 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ANI PHARMACEUTICALS INC DEF 14A filed April 9, 2026, accession 0001023024-26-000039, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025ANI PHARMACEUTICALS pays directors a $59,250 cash retainer and $248,323 in equity.
The rest of the ANI PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Antonio R. Pera | Independent Director | $327,573 |
| Jeanne A. Thoma | Independent Director | $331,330 |
| Matthew J. Leonard | Independent Director | $327,573 |
| Muthusamy Shanmugam | Director | $0 |
| Nikhil Lalwani | Director | $0 |
| Renee P. Tannenbaum | Independent Director | $332,573 |
| Thomas J. Haughey | Independent Director | $343,089 |
The full ANI PHARMACEUTICALS compensation record
free company briefThis page is one director within ANI PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat